SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001651308-20-000091
Filing Date
2020-07-02
Accepted
2020-07-02 16:01:08
Documents
17
Period of Report
2020-06-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K a8-kx02jul2020.htm   iXBRL 8-K 61247
2 EXHIBIT 99.1 ex991.htm EX-99.1 39832
3 EXHIBIT 99.2 ex992.htm EX-99.2 11796
4 EXHIBIT 99.3 ex993.htm EX-99.3 26548
  Complete submission text file 0001651308-20-000091.txt   307938

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bgne-20200702.xsd EX-101.SCH 4441
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bgne-20200702_cal.xml EX-101.CAL 622
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bgne-20200702_def.xml EX-101.DEF 1472
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bgne-20200702_lab.xml EX-101.LAB 27197
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bgne-20200702_pre.xml EX-101.PRE 14088
10 EXTRACTED XBRL INSTANCE DOCUMENT a8-kx02jul2020_htm.xml XML 4493
Mailing Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108
Business Address C/O MOURANT GOVERNANCE SERVICES (CAYMAN) 94 SOLARIS AVENUE, CAMANA BAY GRAND CAYMAN E9 KY1-1108 13459494123
BeiGene, Ltd. (Filer) CIK: 0001651308 (see all company filings)

IRS No.: 981209416 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37686 | Film No.: 201009153
SIC: 2834 Pharmaceutical Preparations